1. Home
  2. CALX vs VERA Comparison

CALX vs VERA Comparison

Compare CALX & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calix Inc

CALX

Calix Inc

HOLD

Current Price

$55.72

Market Cap

4.2B

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$54.04

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CALX
VERA
Founded
1999
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
1.5B
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
CALX
VERA
Price
$55.72
$54.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
11
Target Price
$77.75
$76.60
AVG Volume (30 Days)
832.8K
2.0M
Earning Date
01-28-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$933,685,000.00
N/A
Revenue This Year
$21.58
N/A
Revenue Next Year
$13.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.89
N/A
52 Week Low
$28.61
$18.53
52 Week High
$71.22
$54.57

Technical Indicators

Market Signals
Indicator
CALX
VERA
Relative Strength Index (RSI) 48.89 81.25
Support Level $52.72 $47.22
Resistance Level $56.49 $51.19
Average True Range (ATR) 1.65 3.06
MACD 0.36 0.62
Stochastic Oscillator 74.74 93.89

Price Performance

Historical Comparison
CALX
VERA

About CALX Calix Inc

Calix Inc develops, markets and sells its appliance-based platform, cloud and managed services that enable service providers of all types and sizes to innovate and transform their businesses. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: